News & Updates

Starting DOACs sooner after stroke may be best for AF patients

For secondary stroke prevention in patients with atrial fibrillation (AF), the optimal timing of initiating a direct oral anticoagulant (DOAC) remains elusive, although evidence from a phase II study suggests that earlier initiation is better than later times within the first 2 weeks after stroke onset.

Unhealthy eating: A trigger for eating disorders, altered neurodevelopment?

A study using data from the longitudinal IMAGEN adolescent cohort sheds light on the association between eating behaviours and eating disorders (EDs) and brain maturation.

Intensive BP-lowering therapy safe for patients with acute ICH

Reducing systolic blood pressure (SBP) to a target of less than 140 mm Hg does not appear to have any negative effects on diffusion-weighted imaging lesion frequency and volume in patients with acute intracerebral haemorrhage (ICH), as shown in ICHADAPT-2*.

Long-term use of antidepressants linked to sudden cardiac death

New research presented at EHRA 2025 has shown that patients who have taken antidepressants for extended periods are at increased risk of sudden cardiac death.

Apixaban (Eliquis): Superior anticoagulation efficacy with minimized bleeding risks

Primary stroke mechanism identification helps predict recurrent stroke risk

In medically treated symptomatic intracranial atherosclerotic stenosis (sICAS) patients, considering artery-to-artery embolism (AAE) rather than hypoperfusion as the stroke mechanism for cortical borderzone (CBZ) infarcts could better predict early recurrent stroke in the same territory (SIT), a study by the Chinese University of Hong Kong (CUHK) has found.

Palliative care needed in patients with progressive neurologic diseases

Early recognition and management of emerging palliative care (PC) needs, particularly psychospiritual distress, is crucial for enhancing health-related quality of life (HRQoL) for patients with peripheral neurologic diseases (PNDs), a study by the University of Hong Kong (HKU) has found.  

Meta-analysis favours glucose-lowering with GLP-1RA for dementia risk

In the management of diabetes, users of glucagon-like peptide-1 receptor agonists (GLP-1RAs) appear to have a lower risk of all-cause dementia compared with users of other glucose-lowering medications, according to a systematic review and meta-analysis.

Cognitive function in middle-aged women not worsened by COVID-19 pandemic

COVID-19 pandemic and pandemic-related events do not appear to have resulted in cognitive decline in middle-aged women, according to a study.

Self-perceived stress tied to higher stroke risk in young women

A recent study found that self-perceived stress may increase the risk of early-onset cryptogenic ischaemic stroke (CIS) in young adults, particularly women.